Document

As independent registered public accountants, we hereby consent to the use of our report dated March 14, 2025, with respect to the consolidated financial statements of GRI Bio, Inc. for the years ended December 31, 2024 and 2023, in its Registration Statement on Form S-8 pertaining to the registration of 400,000 shares of common stock as described in the prospectus.